Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Price, Quote, News and Overview

NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD

1.81  +0.06 (+3.43%)

After market: 1.831 +0.02 (+1.16%)

ICU Quote, Performance and Key Statistics

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (3/7/2025, 8:00:02 PM)

After market: 1.831 +0.02 (+1.16%)

1.81

+0.06 (+3.43%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High27.5
52 Week Low1.5
Market Cap15.78M
Shares8.72M
Float8.50M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)04-14 2025-04-14/amc
IPO01-26 2021-01-26


ICU short term performance overview.The bars show the price performance of ICU in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

ICU long term performance overview.The bars show the price performance of ICU in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ICU is 1.81 USD. In the past month the price decreased by -8.12%. In the past year, price decreased by -91.12%.

SEASTAR MEDICAL HOLDING CORP / ICU Daily stock chart

ICU Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 29.37 237.84B
ISRG INTUITIVE SURGICAL INC 70.7 184.84B
BSX BOSTON SCIENTIFIC CORP 39.49 146.29B
SYK STRYKER CORP 31.12 144.73B
MDT MEDTRONIC PLC 17.7 121.20B
BDX BECTON DICKINSON AND CO 16.5 65.91B
EW EDWARDS LIFESCIENCES CORP 26.84 41.35B
GEHC GE HEALTHCARE TECHNOLOGY 19.28 39.59B
IDXX IDEXX LABORATORIES INC 38.23 34.98B
RMD RESMED INC 26.29 34.14B
DXCM DEXCOM INC 47.18 30.42B
PHG KONINKLIJKE PHILIPS NVR- NY 18.25 25.91B

About ICU

Company Profile

ICU logo image SeaStar Medical Holding Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Denver, Colorado and currently employs 12 full-time employees. The company went IPO on 2021-01-26. SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The firm is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The firm's technologies rely on science to provide life-saving solutions to critically ill patients. The firm develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The firm uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Company Info

SEASTAR MEDICAL HOLDING CORP

3513 Brighton Blvd, Suite 410

Denver COLORADO US

Employees: 12

Company Website: https://seastarmedical.com

Investor Relations: https://investors.seastarmedical.com/overview/default.aspx

Phone: 18444278100

SEASTAR MEDICAL HOLDING CORP / ICU FAQ

What is the stock price of SEASTAR MEDICAL HOLDING CORP today?

The current stock price of ICU is 1.81 USD. The price increased by 3.43% in the last trading session.


What is the ticker symbol for SEASTAR MEDICAL HOLDING CORP stock?

The exchange symbol of SEASTAR MEDICAL HOLDING CORP is ICU and it is listed on the Nasdaq exchange.


On which exchange is ICU stock listed?

ICU stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SEASTAR MEDICAL HOLDING CORP stock?

5 analysts have analysed ICU and the average price target is 7.14 USD. This implies a price increase of 294.48% is expected in the next year compared to the current price of 1.81. Check the SEASTAR MEDICAL HOLDING CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SEASTAR MEDICAL HOLDING CORP worth?

SEASTAR MEDICAL HOLDING CORP (ICU) has a market capitalization of 15.78M USD. This makes ICU a Nano Cap stock.


How many employees does SEASTAR MEDICAL HOLDING CORP have?

SEASTAR MEDICAL HOLDING CORP (ICU) currently has 12 employees.


What are the support and resistance levels for SEASTAR MEDICAL HOLDING CORP (ICU) stock?

SEASTAR MEDICAL HOLDING CORP (ICU) has a support level at 1.57 and a resistance level at 1.82. Check the full technical report for a detailed analysis of ICU support and resistance levels.


Should I buy SEASTAR MEDICAL HOLDING CORP (ICU) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SEASTAR MEDICAL HOLDING CORP (ICU) stock pay dividends?

ICU does not pay a dividend.


When does SEASTAR MEDICAL HOLDING CORP (ICU) report earnings?

SEASTAR MEDICAL HOLDING CORP (ICU) will report earnings on 2025-04-14, after the market close.


What is the Price/Earnings (PE) ratio of SEASTAR MEDICAL HOLDING CORP (ICU)?

SEASTAR MEDICAL HOLDING CORP (ICU) does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.38).


What is the Short Interest ratio of SEASTAR MEDICAL HOLDING CORP (ICU) stock?

The outstanding short interest for SEASTAR MEDICAL HOLDING CORP (ICU) is 4.31% of its float. Check the ownership tab for more information on the ICU short interest.


ICU Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ICU Financial Highlights

Over the last trailing twelve months ICU reported a non-GAAP Earnings per Share(EPS) of -12.38. The EPS decreased by -16% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -660.4%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%87.78%
Sales Q2Q%N/A
EPS 1Y (TTM)-16%
Revenue 1Y (TTM)N/A

ICU Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to ICU. The Buy consensus is the average rating of analysts ratings from 5 analysts.


Ownership
Inst Owners2.52%
Ins Owners1.11%
Short Float %4.31%
Short Ratio0.67
Analysts
Analysts80
Price Target7.14 (294.48%)
EPS Next Y73.04%
Revenue Next YearN/A